SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-410228
Filing Date
2014-11-13
Accepted
2014-11-13 07:17:47
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d785749d10q.htm 10-Q 598654
2 EX-31.1 d785749dex311.htm EX-31.1 8896
3 EX-31.2 d785749dex312.htm EX-31.2 8897
4 EX-32.1 d785749dex321.htm EX-32.1 6066
  Complete submission text file 0001193125-14-410228.txt   3061586

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sage-20140930.xml EX-101.INS 338504
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20140930.xsd EX-101.SCH 25492
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20140930_cal.xml EX-101.CAL 36015
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20140930_def.xml EX-101.DEF 117511
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20140930_lab.xml EX-101.LAB 260405
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20140930_pre.xml EX-101.PRE 182775
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 141216284
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences